ScienceDaily (Jan. 25, 2008) — The British-American biotech company Acambis reports the successful conclusion of Phase I trials of the universal flu vaccine in humans. The universal influenza vaccine has been pioneered by researchers from VIB and Ghent University. This vaccine is intended to provide protection against all ‘A’ strains of the virus that causes human influenza, including pandemic strains. Therefore, this vaccine will not need to be renewed annually.
Flanders Institute for Biotechnology (2008, January 25). Universal Influenza Vaccine Tested Successfully In Humans. ScienceDaily. Retrieved January 28, 2008, from http://www.sciencedaily.com /releases/2008/01/080124185522.htm
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment